An unusual cause of hypertrophic cardiomyopathy in an infant: A case report
##plugins.themes.academic_pro.article.main##
Abstract
Introduction: Nemaline myopathy (NM), also known as Nemalinosis, is a rare congenital muscle disease with an incidence of 1 in 50000. It is characterized by nemaline rods in muscle fibers, leading to muscle weakness. We reported a case of NM revealed by cardiac involvement, and we highlighted the challenges in diagnosing this condition as well as its poor prognosis.
Observation: The patient is a 7.5-month-old infant from a consanguineous marriage, with a history of bronchiolitis and psychomotor retardation. The infant was admitted to the paediatric intensive care unit due to respiratory distress, which necessitated intubation and mechanical ventilation. A chest X-ray revealed cardiomegaly and bilateral bronchial syndrome, while an electrocardiogram showed left ventricle hypertrophy. Emergency echocardiography revealed biventricular hypertrophy. Laboratory tests indicated significant rhabdomyolysis, hepatic cytolysis, microcytic hypochromic anaemia, negative troponins, and respiratory acidosis. The enzymatic activity of acid alpha-glucosidase was inconclusive. Genetic analysis for mutations in exon 2 associated with Pompe disease and congenital muscular dystrophy, the most common differential diagnoses, returned negative results. Given the presence of rhabdomyolysis, the emergence of tongue fasciculations, and pronounced axial and peripheral hypotonia, a muscle biopsy was performed. This revealed the presence of nemaline rods, confirming the diagnosis of NM. The patient’s condition deteriorated, marked by extubating failure due to severe muscle weakness. The infant passed away after 50 days of hospitalization.
Conclusion: This case underscores the severity and complexity of NM revealed by hypertrophic cardiomyopathy, emphasizing the importance of early diagnosis and prenatal genetic counseling.
Keywords:
Case report, Congenital, Nemaline myopathy, Mutation##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Wang Q, Hu F. Nemaline myopathy with dilated cardiomyopathy and severe heart failure: A case report. World J Clin cases. 2021;9(11):2569–75.
- Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain. 1963;86(4):793–810.
- Sewry CA, Laitila JM, Wallgren-Pettersson C. Nemaline myopathies: a current view. J Muscle Res Cell Motil. 2019;40(2):111–26.
- Conen Pe, Murphy Eg, Donohue Wl. Light and electron microscopic studies of “myogranules” in a child with hypotonia and muscle weakness. Can Med Assoc J. 1963;89:983–6.
- Finsterer J, Stöllberger C. Review of cardiac disease in nemaline myopathy. Pediatr Neurol. 2015;53(6):473–7.
- Mir A, Lemler M, Ramaciotti C, Blalock S, Ikemba C. Hypertrophic cardiomyopathy in a neonate associated with nemaline myopathy. Congenit Heart Dis. 2012;7(4):1–5.
- Kim SY, Park YE, Kim HS, Lee CH, Yang DH, Kim DS. Nemaline myopathy and non-fatal hypertrophic cardiomyopathy caused by a novel ACTA1 E239K mutation. J Neurol Sci. 2011;307(1–2):171–3.
- D’Amico A, Graziano C, Pacileo G, Petrini S, Nowak KJ, Boldrini R, et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord. 2006;16(9–10):548–52.
- Skyllouriotis ML, Marx M, Skyllouriotis P, Bittner R, Wimmer M. Nemaline myopathy and cardiomyopathy. Pediatr Neurol. 1999;20(4):319–21.
- Lynn Van Antwerpen C, Gospe SM, Dentinger MP. Nemaline myopathy associated with hypertrophic cardiomyopathy. Pediatr Neurol. 1988;4(5):306–8.
- Durling HJ, Reilich P, Müller-Höcker J, Mendel B, Pongratz D, Wallgren-Pettersson C, et al. De novo missense mutation in a constitutively expressed exon of the slow alpha-tropomyosin gene TPM3 associated with an atypical, sporadic case of nemaline myopathy. Neuromuscul Disord. 2002;12(10):947–51.
- Colan SD. Hypertrophic cardiomyopathy in childhood. Heart Fail Clin. 2010;6(4):433–44.
- Hammami R, Ouali S, Naffeti I, Hammas S, Kacem S, Gribaa R, et al. Neonatal hypertrophic cardiomyopathy of difficult etiologic diagnosis Pan Afr Med J. 2011;10 :1-5.
- Yu QX, Zhen L, Lin XM, Wen YJ, Li DZ. Clinical and molecular analysis of nine fetal cases with clinically significant variants causing nemaline myopathy. Eur J Obstet Gynecol Reprod Biol. 2024;292:263–6.
- Haghighi A, Alvandi Z, Nilipour Y, Haghighi A, Kornreich R, Nafissi S, et al. Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, and report of novel genetic variants. Eur J Hum Genet. 2023;31(11):1237–50.
- Wallgren-Pettersson C. Nemaline and myotubular myopathies. Semin Pediatr Neurol. 2002;9(2):132–44.
- Mizue N, Yoshio S, Kentaro K and YF. An infant with congenital nemaline myopathy and hypertrophic cardiomyopathy. J Nippon Med Sch. 2008;75:350―353.
- Polavarapu K, Bardhan M, Anjanappa RM, Vengalil S, Preethish-Kumar V, Shingavi L, et al. Nemaline rod/cap myopathy due to novel homozygous mypn mutations: The first report from south asia and comprehensive literature review. J Clin Neurol. 2021;17(3):409–18.
- Suzan S, Mehmet Y O, Duygu B, Nilufer O, Beril T, Serife S O. Nemaline rod myopathy treated with L-tyrosine to relieve symptoms in a neonate. Arch Argent Pediatr. 2019;117(4).
- Dalal N, Naranje K, Moriangthem A, Singh A. L-tyrosine for treatment of an infant with nemaline rod myopathy. BMJ Case Rep. 2024;17(6).